FI882329A - Polymorfiska former av famotidin och foerfarande foer framstaellning daerav. - Google Patents

Polymorfiska former av famotidin och foerfarande foer framstaellning daerav. Download PDF

Info

Publication number
FI882329A
FI882329A FI882329A FI882329A FI882329A FI 882329 A FI882329 A FI 882329A FI 882329 A FI882329 A FI 882329A FI 882329 A FI882329 A FI 882329A FI 882329 A FI882329 A FI 882329A
Authority
FI
Finland
Prior art keywords
famotidin
polymorphic
former
foerfarande foer
foer framstaellning
Prior art date
Application number
FI882329A
Other languages
English (en)
Finnish (fi)
Other versions
FI882329A0 (fi
Inventor
Montserrat Ballester-Rodes
Francisco Eugen Palomo-Nicolau
Antonio Luis Palomo-Coll
Original Assignee
Marga Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27240404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI882329(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ES8702020A external-priority patent/ES2009147A6/es
Priority claimed from ES8703326A external-priority patent/ES2015339A6/es
Priority claimed from ES8800888A external-priority patent/ES2017246A6/es
Application filed by Marga Investigacion filed Critical Marga Investigacion
Publication of FI882329A0 publication Critical patent/FI882329A0/fi
Publication of FI882329A publication Critical patent/FI882329A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Electron Beam Exposure (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
FI882329A 1987-06-22 1988-05-18 Polymorfiska former av famotidin och foerfarande foer framstaellning daerav. FI882329A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES8702020A ES2009147A6 (es) 1987-06-22 1987-06-22 Nuevo proceso para la preparacion de polimorfos de famotidina
ES8703326A ES2015339A6 (es) 1987-10-29 1987-10-29 Perfeccionamientos a la patente de invencion numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.
ES8800888A ES2017246A6 (es) 1988-03-23 1988-03-23 Mejoras a la patente de invencion, numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.

Publications (2)

Publication Number Publication Date
FI882329A0 FI882329A0 (fi) 1988-05-18
FI882329A true FI882329A (fi) 1988-12-23

Family

ID=27240404

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882329A FI882329A (fi) 1987-06-22 1988-05-18 Polymorfiska former av famotidin och foerfarande foer framstaellning daerav.

Country Status (13)

Country Link
US (1) US5021582A (ko)
EP (1) EP0297019B1 (ko)
JP (1) JPH01100162A (ko)
KR (1) KR920000308B1 (ko)
CN (1) CN1030077A (ko)
AT (1) ATE69052T1 (ko)
AU (1) AU1767288A (ko)
CA (1) CA1322760C (ko)
DE (1) DE3865899D1 (ko)
DK (1) DK342988A (ko)
FI (1) FI882329A (ko)
IL (1) IL86330A0 (ko)
NO (1) NO882037L (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
ES2162867T3 (es) * 1993-07-09 2002-01-16 Scherer Corp R P Metodo de fabricacion de formas de dosificacion de farmacos liofilizados.
CN1196730A (zh) * 1996-06-19 1998-10-21 雷迪博士研究基金会 具有增强的抗糖尿病活性的穴糖酮的新的多晶型形式及其制备方法
JP4755789B2 (ja) * 2001-09-26 2011-08-24 株式会社フジシールインターナショナル ラベル及びその製造方法
CA2426122A1 (en) * 2002-05-02 2003-11-02 M/S Tonira Pharma Limited A process for the preparation of a combination of famotidine polymorphis a and b
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496737A (en) * 1982-09-27 1985-01-29 Merck & Co., Inc. Process for preparing sulfamylamidine antisecretory agents
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
DE3644246A1 (de) * 1986-06-20 1987-12-23 Uriach & Cia Sa J Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances

Also Published As

Publication number Publication date
US5021582A (en) 1991-06-04
KR920000308B1 (ko) 1992-01-11
DK342988A (da) 1988-12-23
DE3865899D1 (de) 1991-12-05
NO882037L (no) 1988-12-23
DK342988D0 (da) 1988-06-22
EP0297019A1 (en) 1988-12-28
ATE69052T1 (de) 1991-11-15
NO882037D0 (no) 1988-05-10
FI882329A0 (fi) 1988-05-18
EP0297019B1 (en) 1991-10-30
IL86330A0 (en) 1988-11-15
KR890000086A (ko) 1989-03-11
CA1322760C (en) 1993-10-05
JPH01100162A (ja) 1989-04-18
AU1767288A (en) 1988-12-22
CN1030077A (zh) 1989-01-04

Similar Documents

Publication Publication Date Title
IT8819213A0 (it) Procedimento e dispositivo per la realizzazione di mescole di caucciu'.
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
NO885213D0 (no) Stabiliserte legemidler, fremgangsmŸte til deres fremstilling samt stabile legemiddeltilberedninger.
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
IT8521763A0 (it) Procedimento per la preparazione di derivati 3-sostituiti dall'1-amino-2-idrossi-propano.
FI882329A (fi) Polymorfiska former av famotidin och foerfarande foer framstaellning daerav.
FR2796380B3 (fr) Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FI884524A (fi) Biskarbamatbaserade herbicidkompositioner och foerfarande foer bekaempning av ograes med dessa.
FR2780404B1 (fr) Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2602771B1 (fr) Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
FR2615188B1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
FR2818277B1 (fr) Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BG60271B1 (bg) 13-алкил-23-имино и 13-хало-23-имино производни на ll-f28249 и приложението им като ендо- и ектопаразитицидни, инсектицидни, акарицидни и нематоцидни средства
IT1216752B (it) Intermedi e procedimenti per lapreparazione di composti tetrazolici antipercolestorolemici.
FR2622194B1 (fr) Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
PT87743A (pt) Process for the preparation of pyrimidine derivatives and of insecticide and acaricide compounds which contain them
FR2585020B1 (fr) Nouvelle substance biologiquement active, appelee girolline, extraite de l'eponge pseudaxinyssa cantharella, son procede de preparation et les compositions pharmaceutiques qui la contiennent
IT8723035A0 (it) Procedimento per la preparazione di n acilaniline.
FR2650278B1 (fr) Procede de preparation de formes non racemiques de derives de la furo (3,4-c) pyridine, composes ainsi obtenus et compositions therapeutiques en contenant
IT8622819A0 (it) Procedimento per la preparazione di composti stabilizzanti e composti stabilizzanti cosi' ottenuti.
FR2719588B1 (fr) Nouveau procédé de préparation de la substance "S" et nouveaux intermédiaires.
FR2588553B3 (fr) Nouveaux derives de la diphenoxyethylamine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: CENTRO MARGA PARA LA INVESTIGACION S.A.